Approved immunotherapy drugs (multi-year total)
STO-REC-STATMBM4FPT2 National
30
United States · 2010–2025
Approved immunotherapy drugs in United States (multi-year total) stood at 30 in 2010–2025 (PhRMA).
- Publisher
- PhRMA
- Authority tier
- T2 National
- Report
- Research & Development
- Locator
- Revolutionizing Cancer Care with Immunotherapy
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
Since 2010, over 30 immunotherapy drugs have been approved to treat 25 types of cancer.
Verbatim extraction verified: The figure 30 is directly attested in the quoted passage (Revolutionizing Cancer Care with Immunotherapy).
The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.
- APA
- PhRMA. (2025). Research & Development. Retrieved September 17, 2026, from https://phrma.org/policy-issues/research-development. Via StatOrigin, https://statorigin.org/stat/stat_MBM4FPC6Q63D53V4H7947N7R0N
- MLA
- PhRMA. "Research & Development." 2025, https://phrma.org/policy-issues/research-development. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_MBM4FPC6Q63D53V4H7947N7R0N.
- Chicago
- PhRMA. "Research & Development." 2025. https://phrma.org/policy-issues/research-development. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_MBM4FPC6Q63D53V4H7947N7R0N.
- BibTeX
- @misc{phrma2025approved7n7r0n, author = {{PhRMA}}, title = {Research \& Development}, year = {2025}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_MBM4FPC6Q63D53V4H7947N7R0N}, note = {Original source: https://phrma.org/policy-issues/research-development. Accessed September 17, 2026.} }
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Chain of Custody · Verification Audit
Primary Source
- Publisher
- PhRMA · homepage ↗
- Authority tier
- Tier 2 · National Official
- Report
- Research & Development
- Type
- Press release
- Published
- —
- Locator
- Revolutionizing Cancer Care with Immunotherapy
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification & Integrity
- Audit status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Archival URI
- /stat/stat_MBM4FPC6Q63D53V4H7947N7R0N